LEADS Trademark

Trademark Overview

On Thursday, April 8, 2021, a trademark application was filed for LEADS with the United States Patent and Trademark Office. The USPTO has given the LEADS trademark a serial number of 90631547. The federal status of this trademark filing is REGISTERED as of Tuesday, July 16, 2024. This trademark is owned by SINOPIA BIOSCIENCES, INC.. The LEADS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information in the fields of drug discovery and therapeutic applications

Research and development services in the fields of drug discovery and diagnostics; consulting in the fields of drug discovery and therapeutic applications
leads

General Information

Serial Number90631547
Word MarkLEADS
Filing DateThursday, April 8, 2021
Status700 - REGISTERED
Status DateTuesday, July 16, 2024
Registration Number7451189
Registration DateTuesday, July 16, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2022

Trademark Statements

Goods and ServicesProviding medical information in the fields of drug discovery and therapeutic applications
Goods and ServicesResearch and development services in the fields of drug discovery and diagnostics; consulting in the fields of drug discovery and therapeutic applications

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 13, 2022
Primary Code042
First Use Anywhere DateTuesday, November 1, 2022
First Use In Commerce DateTuesday, November 1, 2022
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 15, 2021
Primary Code044
First Use Anywhere DateTuesday, November 1, 2022
First Use In Commerce DateTuesday, November 1, 2022

Trademark Owner History

Party NameSINOPIA BIOSCIENCES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameSINOPIA BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameSINOPIA BIOSCIENCES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92101

Trademark Events

Event DateEvent Description
Monday, April 12, 2021NEW APPLICATION ENTERED
Thursday, July 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 29, 2021ASSIGNED TO EXAMINER
Monday, November 29, 2021NON-FINAL ACTION WRITTEN
Monday, November 29, 2021NON-FINAL ACTION E-MAILED
Monday, November 29, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 3, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 3, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 13, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, June 13, 2022EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, June 28, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, July 6, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, July 7, 2022NON-FINAL ACTION WRITTEN
Thursday, July 7, 2022NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 28, 2022ASSIGNED TO LIE
Thursday, August 4, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 17, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 6, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 14, 2023SOU EXTENSION 1 FILED
Thursday, April 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 24, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 13, 2023TEAS STATEMENT OF USE RECEIVED
Friday, October 13, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 13, 2023USE AMENDMENT FILED
Friday, October 13, 2023SOU EXTENSION 2 FILED
Monday, October 23, 2023SOU EXTENSION 2 GRANTED
Wednesday, March 13, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 14, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, October 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 14, 2024NON-FINAL ACTION E-MAILED
Thursday, March 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 7, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

leads discovery drug fields applications therapeutic services diagnostics consulting development research